Literature DB >> 18947507

A 43-year-old African American man with low-risk prostate cancer.

Mark Soloway1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18947507     DOI： 10.1007/s11934-008-0075-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  10 in total

1.  Does age influence the behaviour of localized prostate cancer?

Authors:  C C Parker; M Gospodarowicz; P Warde
Journal:  BJU Int       Date:  2001-05       Impact factor: 5.588

2.  Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.

Authors:  Jason A Efstathiou; Kyounghwa Bae; William U Shipley; Gerald E Hanks; Miljenko V Pilepich; Howard M Sandler; Matthew R Smith
Journal:  Cancer       Date:  2007-12-15       Impact factor: 6.860

3.  Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy.

Authors:  C L Amling; C J Kane; R H Riffenburgh; J F Ward; J L Roberts; R S Lance; P A Friedrichs; J W Moul
Journal:  Urology       Date:  2001-11       Impact factor: 2.649

4.  Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience.

Authors:  Brian Lee; Katsuto Shinohara; Vivian Weinberg; Alexander R Gottschalk; Jean Pouliot; Mack Roach; I-Chow Hsu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-29       Impact factor: 7.038

5.  Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.

Authors:  Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Edward Adamovich
Journal:  Urology       Date:  2004-10       Impact factor: 2.649

6.  The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma.

Authors:  Thomas D Denberg; Fernando J Kim; Robert C Flanigan; Diane Fairclough; Brenda L Beaty; John F Steiner; Richard M Hoffman
Journal:  Med Care       Date:  2006-12       Impact factor: 2.983

7.  Quality of life and satisfaction with outcome among prostate-cancer survivors.

Authors:  Martin G Sanda; Rodney L Dunn; Jeff Michalski; Howard M Sandler; Laurel Northouse; Larry Hembroff; Xihong Lin; Thomas K Greenfield; Mark S Litwin; Christopher S Saigal; Arul Mahadevan; Eric Klein; Adam Kibel; Louis L Pisters; Deborah Kuban; Irving Kaplan; David Wood; Jay Ciezki; Nikhil Shah; John T Wei
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

8.  Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial.

Authors:  Mack Roach; Michelle De Silvio; Timothy Rebbick; David Grignon; Marvin Rotman; Harvey Wolkov; Barbara Fisher; Gerald Hanks; William U Shipley; Alan Pollack; Howard Sandler; Deborah Watkins-Bruner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-10       Impact factor: 7.038

9.  Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer.

Authors:  Laura Ellen Millender; Michele Aubin; Jean Pouliot; Katsuto Shinohara; Mack Roach
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-05-01       Impact factor: 7.038

10.  Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study.

Authors:  Paul L Nguyen; Ming-Hui Chen; Anthony V D'Amico; Clare M Tempany; Graeme S Steele; Michele Albert; Robert A Cormack; David L Carr-Locke; Ronald Bleday; W Warren Suh
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.